StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > at least

<< Previous

Bullboard Posts

Next >>

Comment by Str8Shuteron Feb 26, 2021 3:32pm

143 Views

Post# 32673453

RE:at least

I trade on the TD WebBroker platform. Under the Detailed Analyst Ratings heading, they show Noel's 12-month target of $4.00 was reiterated on 12.08.20. It doesn't appear to me that they are regularly pushed out the target date.

davewho wrote: Morningstars software program still likes us with a fair value of $1.87 Strange that TD keeps punishing Noels $4US target out by a day everyday. Its like the never ending 12 month target. Isnt it based on when he released his report

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments